Try our Advanced Search for more refined results
In Re: Aggrenox Antitrust Litigation
Case Number:
3:14-md-02516
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
Judge:
Firms
- Ahern & Associates
- Baker Donelson
- Baker & Miller
- Ballard Spahr
- Barrett Johnston
- Bass Berry
- Berger Montague
- Blank Rome
- Brenner Saltzman
- Capozzi Adler
- Carmody Torrance
- Cohen Milstein
- Cohen Placitella
- Connolly Wells
- Cowdery Murphy
- Day Pitney
- DiCello Levitt
- Faruqi & Faruqi
- Garwin Gerstein
- Gibson Dunn
- Girard Sharp
- Glancy Prongay
- Goodwin Procter
- Grant & Eisenhofer
- Hagens Berman
- Hangley Aronchick
- Hausfeld LLP
- Hayber McKenna
- Heim Payne
- Heins Mills
- Hilliard & Shadowen
- Hurwitz Sagarin
- Jones Day
- Kenny Nachwalter
- Labaton Keller
- Latham & Watkins
- Lauletta Birnbaum
- Levin Sedran
- Lockridge Grindal
- Lowey Dannenberg
- McCune Wright
- Milberg Coleman
- Miller Shah LLP
- Motley Rice
- Norton Rose
- Nussbaum Law Group
- Odom & Des Roches
- Pomerantz LLP
- Pullman & Comley
- Quinn Connor Weaver
- Reinhardt Wendorf
- Shipman & Goodwin
- Simmons Hanly
- Smith Segura
- Spector Roseman
- Stevens & Lee
- Stoll Berne
- Taus Cebulash
- White & Case
- Wiley Rein
- Winstead PC
- Zayas Law Firm
- Zimmerman Reed
Companies
- Aetna Inc.
- Association for Accessible Medicines
- Bi-Lo
- BlueCross BlueShield of Tennessee Inc.
- Boehringer Ingelheim Vetmedica Inc.
- CVS Health Corp.
- Florida Blue
- Gyma Laboratories of America Inc.
- H‑E‑B LP
- Humana Inc.
- International Union of Painters & Allied Trades
- Rite Aid Corp.
- Rochester Drug Cooperative Inc.
- Safeway Inc.
- Teva Pharmaceutical Industries Ltd.
- The Cigna Group
- The Kroger Co.
- Winn-Dixie Stores, Inc.
Sectors & Industries:
-
December 09, 2015
Drug Cos. Ask Court To Delay Decision Over Aggrenox Market
Boehringer Ingelheim and Teva urged a Connecticut federal court Tuesday to hold off on devising a method for determining the relevant product market in multidistrict litigation accusing the drugmakers of scheming to keep generic versions of the stroke-prevention drug Aggrenox off the market, saying it was premature to do so.
-
November 16, 2015
Boehringer, Teva Slam Aggrenox Buyers' Doc Production
Boehringer Ingelheim and Teva on Friday told a Connecticut federal judge that the direct purchasers accusing them in multidistrict litigation of scheming to keep generic versions of the stroke-prevention drug Aggrenox off the market won't cooperate in discovery, by refusing to search for more than three terms.
-
November 02, 2015
BCBS Fights Dismissal Bid In Aggrenox Pay-For-Delay Suit
Louisiana Blue Cross/Blue Shield urged a Connecticut federal court Friday not to dismiss the insurer's state antitrust claims from multidistrict litigation accusing Boehringer Ingelheim Pharmaceuticals Inc. of scheming to keep generic versions of the stroke-prevention drug Aggrenox off the market, saying they are supported by several states' laws.
-
September 22, 2015
Aggrenox Buyers Blast Discovery Bid In Antitrust MDL
Direct purchasers in multidistrict litigation accusing Boehringer Ingelheim Pharmaceuticals Inc. of scheming to keep generic versions of the stroke-prevention drug Aggrenox off the market slammed discovery requests regarding several other drugs with which it "evidently" competes, calling the requests "enormously burdensome."
-
August 17, 2015
Aggrenox Plaintiffs Say Boehringer's Lidoderm Take Is Wrong
Drugstore chains accusing Boehringer Ingelheim Pharmaceuticals Inc. of scheming to keep generic versions of the stroke drug Aggrenox off the market shot back at the defendants' arguments that a recent ruling fails to bolster their case, telling a Connecticut federal court Monday that order supports their injunction bid.
-
August 10, 2015
Humana, Worker Funds Fight To Preserve Pay-For-Delay MDL
Humana Inc. and a group of employee health funds separately asked a Connecticut federal judge Friday to deny dismissal bids by Teva Pharmaceuticals USA Inc. and Boehringer Ingelheim Pharmaceuticals Inc. in multidistrict litigation accusing them of a pay-for-delay scheme over a generic version of stroke drug Aggrenox.
-
July 22, 2015
Teva, Boehringer Get Quick Appeal In Pay-For-Delay MDL
A Connecticut federal judge overseeing multidistrict litigation alleging Teva Pharmaceuticals USA Inc. and Boehringer Ingelheim Pharmaceuticals Inc. engaged in a pay-for-delay scheme over a generic version of stroke drug Aggrenox cleared the drugmakers to immediately appeal an order that kept intact most federal claims against them.
-
June 03, 2015
Teva, Others Seek To Nix Retailers' Pay-For-Delay Suits
Teva Pharmaceuticals USA Inc., Boehringer Ingelheim Pharmaceuticals Inc. and other pharmaceutical companies accused in multidistrict litigation of engaging in a pay-for-delay scheme over the stroke drug Aggrenox told a Connecticut federal court to toss complaints by six retailers because they didn't show they directly bought the drug.
-
April 27, 2015
Humana Urges Court Not To Allow Drug Cos.' Aggrenox Appeal
A Connecticut federal court should not send its recent order largely refusing to dismiss a pay-for-delay suit over stroke drug Aggrenox to the Second Circuit for interlocutory review, Humana Inc. argued Monday.
-
April 06, 2015
Drug Cos. Want 2nd Circ. To Hear Bid To Nix Aggrenox Claims
Teva Pharmaceuticals USA Inc. and Boehringer Ingelheim Pharmaceuticals Inc. have asked a Connecticut court to send its recent order largely refusing to dismiss a pay-for-delay suit over stroke drug Aggrenox to the Second Circuit for review.
- ← Previous
- 1
- 2
- 3
- 4
- Next →